newsfilter
← Latest News
GlobeNewswire·

Adverum Biotechnologies Appoints Romuald Corbau, Ph.D. as Chief Scientific Officer

REDWOOD CITY, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular